MPO and Crohn ileitis: The injection of rmIL-33 (0.5 μg daily by i.p. route) in infected B6 mice augmented the inflammatory response with increased MPO activity and KC expression in the ileum and reduced survival due to enhanced severity of the ileitis confirmed by microscopic analysis (Figures 4E-H).